Health Benefits of Whole Grains
The 2015 Dietary Guidelines for Americans recommend replacing refined grains with whole grains so that…
Author: American Council on Exercise
Vitamin K: Beyond Blood Clotting
Vitamin K was named for its role in coagulation (koagulation in German), but it turns…
News Bites: Vitamin D and Cancer; Diabetes Apps; Omega-6
Vitamin D and Cancer A randomized trial recently published in the Journal of the American Medical…
What, Exactly, is a Mediterranean Diet?
Although it has been the subject of numerous health, weight loss, and cooking books, the…
Ask the Experts: Feeling Faint; Pulmonary Rehabilitation; Flexitarian Diet
Q: I’ve been experiencing feelings of faintness just recently, though I haven’t actually fainted. They…
Obesity Surgery an Effective Option for Some Seniors
Defined as having a body mass index (BMI, a ratio of height to weight) of…
Hire the Right In-Home Caregiver
There’s no place like home for many elderly adults, according to a recent survey from…
Are Your Memory Lapses Normal?
Some memory change is normal as you age. Even if differences in your memory performance…
From the Editor: Tuning Up Your Memory
Most older adults experience the memory lapses that have been termed “senior moments,” and in…
Kids’ classes focus on healthy eating, alternative choices – Coshocton Tribune
Kids’ classes focus on healthy eating, alternative choices Coshocton Tribune Collette Burdette is the new SNAP-Ed…
Mighty Microgreens
The Folklore. Microgreens may be true to their name in terms of their tiny size…
How to Avoid a Sore Back From Yard Work This Summer – Health Essentials from Cleveland Clinic
How to Avoid a Sore Back From Yard Work This Summer Health Essentials from Cleveland Clinic…
8 Dietary Supplements for Arthritis
Alternative treatment options can be a good adjunct to medication when it comes to managing…
.jpg)
America’s mental health system may be unfixable. Fortunately, there’s an alternative – Salon
America’s mental health system may be unfixable. Fortunately, there’s an alternative Salon The mental health system…
Alternative medicine therapist in Radford facing charges – ABC News
Alternative medicine therapist in Radford facing charges ABC News Authorities in southwest Virginia have charged an…
Psoriasis patients frequently use complementary or alternative therapies to treat their symptoms – News-Medical.net
Psoriasis patients frequently use complementary or alternative therapies to treat their symptoms News-Medical.net Patients with psoriasis…
Merck Hosts 2019 Investor Day Outlining Business Momentum, Strong Expected Growth and Focus on Innovative Research and Development
Dateline City: KENILWORTH, N.J. Momentum Across Key Pillars Expected to Drive Strong Revenue Growth Every…
Psoriasis patients turn to alternative medicine when traditional treatments fail – Science Daily
Psoriasis patients turn to alternative medicine when traditional treatments fail Science Daily A recent survey from…
AstraZeneca and Merck’s LYNPARZA® (olaparib) Approved in Japan as First-Line Maintenance Therapy in Patients with BRCA-Mutated Advanced Ovarian Cancer
Dateline City: KENILWORTH, N.J. LYNPARZA is the Only PARP Inhibitor Approved in Japan KENILWORTH, N.J.–(BUSINESS…
Kittery alternative health store a labor of love for owner – Seacoastonline.com
Kittery alternative health store a labor of love for owner Seacoastonline.com KITTERY, Maine — A former…
R.I. budget contains $1 million for alternative therapy provided by Mattiello donor – The Providence Journal
R.I. budget contains $1 million for alternative therapy provided by Mattiello donor The Providence Journal House…
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Monotherapy for Patients with Metastatic Small Cell Lung Cancer (SCLC) with Disease Progression on or After Platinum-Based Chemotherapy and at Least One Other Prior Line of Therapy
Dateline City: KENILWORTH, N.J. Marks First Approval for KEYTRUDA in SCLC KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK),…
LYNPARZA® (olaparib) Approved in the EU for Use as First-Line Maintenance Therapy in Patients With BRCA-Mutated Advanced Ovarian Cancer
Dateline City: KENILWORTH, N.J. AstraZeneca and Merck’s LYNPARZA Reduced the Risk of Disease Progression or…
Radford ‘family alternative therapist’ indicted on 64 counts of practicing without license – WSLS 10
Radford ‘family alternative therapist’ indicted on 64 counts of practicing without license WSLS 10 A Radford…
Radford alternative medicine therapist charged with 64 counts of practicing without a license – Roanoke Times
Radford alternative medicine therapist charged with 64 counts of practicing without a license Roanoke Times A…
Civica Rx contracts with Vizient to anticipate drug price, availability – Healthcare Dive
Civica Rx contracts with Vizient to anticipate drug price, availability Healthcare Dive Provider-led generic drug company…
Employer-Led Group Purchasing Coalition Selects EnvisionRx as Alternative to Traditional Pharmacy Benefit Management Choices – Yahoo Finance
Employer-Led Group Purchasing Coalition Selects EnvisionRx as Alternative to Traditional Pharmacy Benefit Management Choices Yahoo Finance…
Empower Clinics Launches Sun Valley Health and National Franchise Program – Yahoo Finance
Empower Clinics Launches Sun Valley Health and National Franchise Program Yahoo Finance VANCOUVER , June 18,…
Global Foot bath Market 2019 – CONAIR, Alternative Health Clinic, Brookstone, New Shining Image, humaility, RGV, Arogya – Industry News Store
Global Foot bath Market 2019 – CONAIR, Alternative Health Clinic, Brookstone, New Shining Image, humaility,…
New health reimbursement rules provide alternative path to Affordable Care Act compliance – Lexology
New health reimbursement rules provide alternative path to Affordable Care Act compliance Lexology Seemingly unfazed by…
CMS head warned about consequences of ACA changes – HealthExec
CMS head warned about consequences of ACA changes HealthExec The Trump administration was warned that its…
Vaping not safe alternative to cigarettes, experts say – Park Rapids Enterprise
Vaping not safe alternative to cigarettes, experts say Park Rapids Enterprise Though they have fewer chemicals…
Vaping not safe alternative to cigarettes, experts say – Alexandria Echo Press
Vaping not safe alternative to cigarettes, experts say Alexandria Echo Press Though they have fewer chemicals…
Feature: Health tourism in Turkey offers hope for foreign patients – Xinhua | English.news.cn – Xinhua
Feature: Health tourism in Turkey offers hope for foreign patients – Xinhua | English.news.cn Xinhua by…
‘I’m Feeling Great’: How New Treatment Saved 10-Year-Old Boy’s Life After Two Bouts Of Cancer – CBS Philly
‘I’m Feeling Great’: How New Treatment Saved 10-Year-Old Boy’s Life After Two Bouts Of Cancer CBS…
Vaping not safe alternative to cigarettes, experts say – Grand Forks Herald
Vaping not safe alternative to cigarettes, experts say Grand Forks Herald Though they have fewer chemicals…
List of Lists: Alternative Medicine – Colorado Springs Business Journal
List of Lists: Alternative Medicine Colorado Springs Business Journal See the top 5 alternative medicine businesses…
.jpg)
New Final Rule Expands Access to HRAs – HealthLeaders Media
New Final Rule Expands Access to HRAs HealthLeaders Media Feds say the new rule will benefit…
IBM, KPMG, Merck and Walmart to collaborate as part of FDA’s program to evaluate the use of blockchain to protect pharmaceutical product integrity
Dateline City: ARMONK, N.Y., NEW YORK, N.Y., KENILWORTH, N.J., and BENTONVILLE, Ark. The FDA pilot…
FDA Approves Two New Indications for Merck’s KEYTRUDA® (pembrolizumab)
Dateline City: KENILWORTH, N.J. KEYTRUDA Now Approved for First-Line Treatment of Patients with Metastatic or…
Merck to Acquire Tilos Therapeutics
Dateline City: KENILWORTH, N.J. Merck Gains Portfolio of Investigational Antibodies Modulating TGFβ KENILWORTH, N.J.–(BUSINESS WIRE)–Merck…
FDA Approves Merck’s ZERBAXA® (ceftolozane and tazobactam) 3g Dose for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)
Dateline City: KENILWORTH, N.J. Approval Based on Results of Phase 3 Trial Evaluating Critically Ill…
LYNPARZA® (olaparib) Phase 3 SOLO3 Trial Demonstrated a 72% Objective Response Rate in Patients with Platinum-Sensitive Relapsed Germline BRCA-mutated Advanced Ovarian Cancer Compared to 51% of Patients Receiving Chemotherapy
Dateline City: KENILWORTH, N.J. AstraZeneca and Merck’s LYNPARZA Increased the Median Time Without Disease Progression…
LYNPARZA® (olaparib) First-Line Maintenance Therapy Nearly Doubled the Time Without Disease Progression or Death in Phase 3 POLO Trial for Patients with Germline BRCA-Mutated Metastatic Pancreatic Cancer
Dateline City: KENILWORTH, N.J. 22% of Patients Receiving LYNPARZA Remained Progression-Free After Two Years vs….
Five-Year Survival Data for Merck’s KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer (NSCLC) from First KEYNOTE Trial at 2019 ASCO Annual Meeting
Dateline City: KENILWORTH, N.J. Longest Follow-Up Data for KEYTRUDA in Lung Cancer to Date Showed…
Results Evaluating Merck’s KEYTRUDA® (pembrolizumab) for First-Line Treatment of Patients with Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma to be Presented at 2019 ASCO Annual Meeting
Dateline City: KENILWORTH, N.J. First Randomized Phase 3 Trial Evaluating an Anti-PD-1 Therapy as Monotherapy…
Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at Final Analysis of Pivotal Phase 3 KEYNOTE-048 Trial
Dateline City: KENILWORTH, N.J. Survival Benefit Now Observed with KEYTRUDA in Combination with Chemotherapy in…
Merck Announces Third-Quarter 2019 Dividend
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United…
Merck Foundation Announces Grant to American Cancer Society to Improve Access to Cancer Care in Resource-Limited Settings
Dateline City: KENILWORTH, N.J. $1.99 Million Grant Supports Patient Navigation Initiative in Sub-Saharan Africa KENILWORTH,…
Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline
Dateline City: KENILWORTH, N.J. & DALLAS Acquisition Includes Novel Late-Stage Renal Cell Carcinoma Candidate, PT2977…